This bidirectional relationship offers a compelling therapeutic opportunity; by modulating the microbiota with targeted antioxidant interventions, it may be possible to reduce inflammation, improve insulin sensitivity, and restore metabolic homeostasis in individuals with type 2 diabetes mellitus [207]. The gene discussed is INS; the disease is type 2 diabetes mellitus.